A major trial has found a single iron infusion in the third trimester can significantly reduce anaemia in pregnant women and outperform the efficacy of iron tablets -- the current recommended standard ...
SP-420 is under clinical development by Pharmacosmos and currently in Phase II for Beta Thalassaemia. According to GlobalData, Phase II drugs for Beta Thalassaemia have a 38% phase transition success ...